Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump listens as Dr. Marty Makary ...

Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are ...

Artificial intelligence (AI) has become one of the defining technologies of what economists and policymakers describe as the Fourth Industrial Revolution. This is an era in which digital, physical, ...

A startup born from personal tragedy is collaborating with Duke Cancer Institute to develop AI tools for patients facing ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

Patients worried about potential side effects of statins can rest easy, according to a new large-scale study: The vast majority of adverse effects listed on statin medications simply never occur. The ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

New research suggests that it’s rare to experience most of the listed side effects for this common type of cholesterol-lowering medication. Misconceptions that statins come with a high risk of side ...

Benefits of statins greatly outweigh risks, study leader says Wrongly attributed side effects may discourage use by patients and doctors Regulators should change statin labeling, researchers say Feb 5 ...

The long list of side effects associated with statins is vastly overstated, according to the most rigorous assessment of the evidence to date. This is prompting calls for the drugs’ packaging to be ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...